Carfilzomib Impurities and its Related Products
Displaying
39 results of
Carfilzomib Impurities
Carfilzomib is a proteasome inhibitor used in the treatment of multiple myeloma. However, during the manufacturing process of carfilzomib, impurities may be formed. These impurities can be harmful and affect the quality, efficacy, and safety of the final product. Therefore, it is important to identify and control these impurities to ensure the purity and stability of carfilzomib. The most common impurities in carfilzomib include related compounds, degradation products, and residual solvents. Analytical methods such as HPLC, LC-MS, and NMR are used to detect and quantify these impurities.